Similar Articles
2261 Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis
2262 Expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma
2263 Adenovirus-mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation
2264 Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma
2265 Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues
2266 Fumagillin treatment of hepatocellular carcinoma in rats: An in vivo study of antiangiogenesis
2267 Tumor vaccine against recurrence of hepatocellular carcinoma
2268 Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721
2269 Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantation - a case report
2270 Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA